Al-Sabah Arrhythmia Institute and Division of Cardiology, The St. Luke's and Roosevelt Hospitals, Columbia University College of Physicians & Surgeons, New York, New York, USA.
Heart Rhythm. 2011 Jun;8(6):858-63. doi: 10.1016/j.hrthm.2011.01.039. Epub 2011 Feb 2.
The implantable loop recorder (ILR) is particularly useful for monitoring patients with syncope, given the episodic nature and unpredictable pattern of recurrent episodes. Current practice guidelines advocate ILR implantation in select patients with unexplained syncope.
The purpose of this study was to evaluate the clinical utility and potential advantages of a novel wireless ILR in a consecutive cohort of patients with unexplained syncope.
Patients with unexplained syncope despite a comprehensive evaluation who underwent implantation of a Transoma Medical Sleuth ILR were examined. ILR implantation was considered in these patients if left ventricular function was ≥ 40% and if syncope was recurrent, associated with trauma, and/or associated with an abnormal ECG (e.g., bifascicular block).
The Sleuth ILR was implanted in 50 patients. During mean follow-up 293 ± 211 days, 16 (32%) patients had recurrent near-syncope or syncope. Only half of the patients self-activated the ILR; in the other half, a diagnosis was established based on autoactivation-initiated storage of a significant arrhythmia event. Overall, there were 5 patients with complete heart block, 3 with sinus node dysfunction, 3 with supraventricular tachycardia, 2 with neurally mediated syncope, and 3 with a nonarrhythmic cause of syncope. The median time from an event to physician notification was 150 minutes (interquartile range 99, 297 min). Median time from ILR implantation to final diagnosis was 71 days (interquartile range 24, 143 days; range 3-683 days).
A diagnosis of syncope was ultimately made in nearly one third of patients with unexplained syncope. Patients frequently did not activate their ILR at the time of recurrent syncope. However, the wireless ILR automatically transferred ECG data to a central monitoring station within minutes to hours of the arrhythmic event, virtually eliminating the possibility of data loss, thus greatly facilitating clinical decision making.
鉴于晕厥的发作性和复发性事件不可预测的特点,植入式环路记录器(ILR)特别适用于监测晕厥患者。目前的实践指南主张在不明原因晕厥的选择患者中植入 ILR。
本研究旨在评估一种新型无线 ILR 在连续队列不明原因晕厥患者中的临床应用价值和潜在优势。
对接受 Transoma Medical Sleuth ILR 植入的不明原因晕厥且经全面评估的患者进行检查。如果左心室功能≥40%,且晕厥反复发作、伴有创伤和/或伴有异常心电图(如双束支阻滞),则考虑植入 ILR。
50 例患者植入了 Sleuth ILR。平均随访 293±211 天期间,16(32%)例患者出现复发性近乎晕厥或晕厥。只有一半的患者自行激活了 ILR;在另一半患者中,基于自动激活存储的显著心律失常事件,确定了诊断。总体而言,有 5 例患者出现完全性心脏阻滞,3 例患者出现窦房结功能障碍,3 例患者出现室上性心动过速,2 例患者出现神经介导性晕厥,3 例患者出现非心律失常性晕厥。从事件到医生通知的中位时间为 150 分钟(四分位距 99,297 分钟)。从 ILR 植入到最终诊断的中位时间为 71 天(四分位距 24,143 天;范围 3-683 天)。
近三分之一的不明原因晕厥患者最终做出了晕厥的诊断。患者在复发性晕厥时经常未激活他们的 ILR。然而,无线 ILR 可在心律失常事件发生后几分钟至数小时内自动将心电图数据传输到中央监测站,几乎消除了数据丢失的可能性,从而极大地促进了临床决策。